- Investing Ideas
- Indian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Indian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
8
Value score of at least 4 focused on companies with a low market cap.
8 companies
Infinium Pharmachem
Market Cap: ₹3.3b
Engages in the manufacture and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs) in India and internationally.
INFINIUM
₹210.70
7D
1.7%
1Y
-27.6%
Haleos Labs
Market Cap: ₹4.8b
Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
HALEOSLABS
₹1,589.10
7D
0.1%
1Y
32.8%
Sotac Pharmaceuticals
Market Cap: ₹1.1b
Engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.
SOTAC
₹95.10
7D
-4.9%
1Y
-23.3%
Amwill Health Care
Market Cap: ₹855.2m
A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.
544353
₹42.75
7D
4.7%
1Y
-37.5%
Brooks Laboratories
Market Cap: ₹2.0b
Provides contract development and manufacturing services for pharmaceutical companies in India and internationally.
BROOKS
₹67.75
7D
-3.0%
1Y
-57.4%
Coral Laboratories
Market Cap: ₹2.1b
Manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.
524506
₹600.05
7D
-0.8%
1Y
3.1%
Par Drugs and Chemicals
Market Cap: ₹1.3b
Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.
PAR
₹102.57
7D
11.9%
1Y
-8.0%
Sunil Healthcare
Market Cap: ₹728.0m
Engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally.
537253
₹70.99
7D
4.8%
1Y
-16.4%